Kaizen Financial Strategies 10x Genomics, Inc. Transaction History
Kaizen Financial Strategies
- $175 Million
- Q1 2024
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
310Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$170 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$139 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$118 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$112 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$96.7 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.78B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...